Multi-node quantitative assessment system and method for symptoms of Parkinson's disease

Abstract

The invention discloses a multi-node quantitative assessment system for symptoms of Parkinson's disease. The multi-node quantitative assessment system comprises a plurality of movement and myoelectricity detection modules, a voice recording module and terminal processing equipment, wherein each movement and myoelectricity detection module is provided with a first microprocessor, a movement sensor and myoelectricity sensor, a first WiFi communication module and a first power management module; the voice recording module is provided with a microphone, a signal conditioning circuit, an analog-digital converter, a second microprocessor and a second WiFi communication module which are electrically connected in sequence and connected to the output end of a second power management module; the terminal processing module is provided with a display screen, a loudspeaker and a third WiFi communication module. The invention further discloses a multi-node quantitative assessment method for symptoms of Parkinson's disease. By means of the multi-node quantitative assessment system and method for symptoms of parkinson's disease, the movement function of a patient can be evaluated objectively through movement and myoelectricity signals of different portions of the body of the patient, and a quantitative index is given to each movement function evaluation content.

Description

technical field [0001] The invention relates to the field of quantitative evaluation of motor system diseases in biomedical engineering. More specifically, the present invention relates to a system and method for quantitative assessment of multi-node Parkinson's disease symptoms. Background technique [0002] Parkinson's disease (Parkinson's Disease, PD), also known as Parkinson's syndrome or Parkinson's syndrome, is a chronic degenerative disorder of the central nervous system. The disease mostly occurs in the elderly, with an average age of onset of about 60 years old, and the age of onset of the disease has a downward trend in recent years. In my country, according to statistics, the incidence rate of PD in people over 65 years old is 1.7%, and the incidence rate of PD in people over 55 years old is 1%. PD has become the "third killer" of middle-aged and elderly people, seriously threatening human life and health. [0003] The clinical symptoms of PD are divided into m...

AI Technical Summary

Problems solved by technology

[0004] At present, clinicians mainly rely on scoring scales to assess the symptoms of motor dysfunction in PD patients, but the scale method is affected by the scoring physician's operating experience and the patient's state and emotion at the time of assessment.

Therefore, it is not objective and accurate to rely on scoring scales to evaluate the motor function of PD patients, which will affect the early diagnosis and staging of PD.

At the same time, the scale method can only evaluate the motor function of PD patients at a certain point in time, and cannot achieve long-term continuous monitoring, which is of great significance to the treatment of PD patients

Images